Skip to main content
Erschienen in: Heart Failure Reviews 4/2017

03.06.2017

The role of myocardial viability in contemporary cardiac practice

verfasst von: Abdelrahman Jamiel, Mohamad Ebid, Amjad M. Ahmed, Dalia Ahmed, Mouaz H. Al-Mallah

Erschienen in: Heart Failure Reviews | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Ischemic heart disease (IHD) remains the single most common cause of death worldwide. Ischemic cardiomyopathy is a major sequel of coronary artery disease. The economic health burden of IHD is substantial. In patients with old myocardial infarction (OMI), the extent of viable myocardium (VM) directly affects the short- and long-term outcome. There is a considerable collection of observational data showing substantial improvement in patients with significant left ventricular dysfunction when the need for revascularization is guided by preoperative assessment of viability and hibernation. However, a major challenge for present cardiovascular imaging is to identify better ways to assess viable but inadequately perfused myocardium and thus optimize selection of patients for coronary revascularization. Several non-invasive techniques have been developed to detect signs of viability. Hence, our aim is to provide the reader a state-of-the art review for the assessment of myocardial viability.
Literatur
1.
Zurück zum Zitat Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362(23):2155–2165PubMedCrossRef Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362(23):2155–2165PubMedCrossRef
2.
Zurück zum Zitat Gheorghiade M, Bonow RO (1998) Chronic heart failure in the United States. Circulation 97(3):282–289PubMedCrossRef Gheorghiade M, Bonow RO (1998) Chronic heart failure in the United States. Circulation 97(3):282–289PubMedCrossRef
3.
Zurück zum Zitat Moschetti K, Petersen SE, Pilz G, Kwong RY, Wasserfallen J-B, Lombardi M, Korosoglou G, Van Rossum AC, Bruder O, Mahrholdt H (2016) Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson 18(1):3PubMedPubMedCentralCrossRef Moschetti K, Petersen SE, Pilz G, Kwong RY, Wasserfallen J-B, Lombardi M, Korosoglou G, Van Rossum AC, Bruder O, Mahrholdt H (2016) Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson 18(1):3PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després J-P, Fullerton HJ (2016) Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133(4):447PubMedCrossRef Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després J-P, Fullerton HJ (2016) Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133(4):447PubMedCrossRef
5.
Zurück zum Zitat Phillips LM, Hachamovitch R, Berman DS, Iskandrian AE, Min JK, Picard MH, Kwong RY, Friedrich MG, Scherrer-Crosbie M, Hayes SW (2013) Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. J Nucl Cardiol 20(6):969–975PubMedPubMedCentralCrossRef Phillips LM, Hachamovitch R, Berman DS, Iskandrian AE, Min JK, Picard MH, Kwong RY, Friedrich MG, Scherrer-Crosbie M, Hayes SW (2013) Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. J Nucl Cardiol 20(6):969–975PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150PubMedCrossRef Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150PubMedCrossRef
7.
Zurück zum Zitat Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549PubMedCrossRef Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549PubMedCrossRef
10.
Zurück zum Zitat Schinkel AF, Poldermans D, Vanoverschelde J-LJ, Elhendy A, Boersma E, Roelandt JR, Bax JJ (2004) Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction. Am J Cardiol 93(1):14–17PubMedCrossRef Schinkel AF, Poldermans D, Vanoverschelde J-LJ, Elhendy A, Boersma E, Roelandt JR, Bax JJ (2004) Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction. Am J Cardiol 93(1):14–17PubMedCrossRef
11.
Zurück zum Zitat Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH (2007) Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32(7):375–410PubMedCrossRef Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH (2007) Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32(7):375–410PubMedCrossRef
12.
Zurück zum Zitat Dowsley T, Al-Mallah M, Ananthasubramaniam K, Dwivedi G, McArdle B, Chow BJ (2013) The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. Can J Cardiol 29(3):285–296PubMedCrossRef Dowsley T, Al-Mallah M, Ananthasubramaniam K, Dwivedi G, McArdle B, Chow BJ (2013) The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. Can J Cardiol 29(3):285–296PubMedCrossRef
13.
Zurück zum Zitat Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314(14):884–888PubMedCrossRef Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314(14):884–888PubMedCrossRef
14.
Zurück zum Zitat Dilsizian V (1996) Myocardial viability: contractile reserve or cell membrane integrity? J Am Coll Cardiol 28(2):443–446PubMedCrossRef Dilsizian V (1996) Myocardial viability: contractile reserve or cell membrane integrity? J Am Coll Cardiol 28(2):443–446PubMedCrossRef
15.
Zurück zum Zitat Braunwald E, Rutherford JD (1986) Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J Am Coll Cardiol 8(6):1467–1470PubMedCrossRef Braunwald E, Rutherford JD (1986) Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J Am Coll Cardiol 8(6):1467–1470PubMedCrossRef
16.
Zurück zum Zitat Rahimtoola S (1985) A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72(6 Pt 2):V123–V135PubMed Rahimtoola S (1985) A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72(6 Pt 2):V123–V135PubMed
17.
18.
Zurück zum Zitat Vanoverschelde J, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA (1993) Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87(5):1513–1523PubMedCrossRef Vanoverschelde J, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA (1993) Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87(5):1513–1523PubMedCrossRef
19.
Zurück zum Zitat Buxton DB (1993) Dysfunction in collateral-dependent myocardium. Hibernation or repetitive stunning? Circulation 87(5):1756–1758PubMedCrossRef Buxton DB (1993) Dysfunction in collateral-dependent myocardium. Hibernation or repetitive stunning? Circulation 87(5):1756–1758PubMedCrossRef
21.
Zurück zum Zitat Bonow RO (1999) Contractile reserve and coronary blood flow reserve in collateral-dependent myocardium. J Am Coll Cardiol 33(3):705–707PubMedCrossRef Bonow RO (1999) Contractile reserve and coronary blood flow reserve in collateral-dependent myocardium. J Am Coll Cardiol 33(3):705–707PubMedCrossRef
22.
Zurück zum Zitat Heyndrickx G, Millard R, McRitchie R, Maroko P, Vatner S (1975) Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Investig 56(4):978PubMedPubMedCentralCrossRef Heyndrickx G, Millard R, McRitchie R, Maroko P, Vatner S (1975) Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Investig 56(4):978PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Moon JC, De Arenaza DP, Elkington AG, Taneja AK, John AS, Wang D, Janardhanan R, Senior R, Lahiri A, Poole-Wilson PA (2004) The pathologic basis of Q-wave and non-Q-wave myocardial infarction. J Am Coll Cardiol 44(3):554–560PubMedCrossRef Moon JC, De Arenaza DP, Elkington AG, Taneja AK, John AS, Wang D, Janardhanan R, Senior R, Lahiri A, Poole-Wilson PA (2004) The pathologic basis of Q-wave and non-Q-wave myocardial infarction. J Am Coll Cardiol 44(3):554–560PubMedCrossRef
29.
Zurück zum Zitat Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI (2016) ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 23(5):1187–1226PubMedCrossRef Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI (2016) ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 23(5):1187–1226PubMedCrossRef
30.
Zurück zum Zitat Dilsizian V, Bonow RO (1993) Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87(1):1–20PubMedCrossRef Dilsizian V, Bonow RO (1993) Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87(1):1–20PubMedCrossRef
31.
Zurück zum Zitat Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM (2003) Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy. Circulation 108(16):1945–1953PubMedCrossRef Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM (2003) Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy. Circulation 108(16):1945–1953PubMedCrossRef
32.
Zurück zum Zitat Doltra A, Hoyem Amundsen B, Gebker R, Fleck E, Kelle S (2013) Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev 9(3):185–190PubMedPubMedCentralCrossRef Doltra A, Hoyem Amundsen B, Gebker R, Fleck E, Kelle S (2013) Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev 9(3):185–190PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100(19):1992–2002PubMedCrossRef Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100(19):1992–2002PubMedCrossRef
34.
Zurück zum Zitat Gewirtz H, Dilsizian V (2016) Integration of quantitative positron emission tomography absolute myocardial blood flow measurements in the clinical management of coronary artery disease. Circulation 133(22):2180–2196PubMedCrossRef Gewirtz H, Dilsizian V (2016) Integration of quantitative positron emission tomography absolute myocardial blood flow measurements in the clinical management of coronary artery disease. Circulation 133(22):2180–2196PubMedCrossRef
35.
Zurück zum Zitat Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, Summers RM, Quyyumi AA, Dilsizian V (1999) 13N-ammonia myocardial blood flow and uptake. J Am Coll Cardiol 33(3):678–686PubMedCrossRef Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, Summers RM, Quyyumi AA, Dilsizian V (1999) 13N-ammonia myocardial blood flow and uptake. J Am Coll Cardiol 33(3):678–686PubMedCrossRef
36.
Zurück zum Zitat Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO (1990) Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323(3):141–146. doi:10.1056/nejm199007193230301 Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO (1990) Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323(3):141–146. doi:10.​1056/​nejm199007193230​301
37.
Zurück zum Zitat Gewirtz H, Beller GA, Strauss HW, Dinsmore RE, Zir LM, Mckusick KA, Pohost GM (1979) Transient defects of resting thallium scans in patients with coronary artery disease. Circulation 59(4) Gewirtz H, Beller GA, Strauss HW, Dinsmore RE, Zir LM, Mckusick KA, Pohost GM (1979) Transient defects of resting thallium scans in patients with coronary artery disease. Circulation 59(4)
38.
Zurück zum Zitat Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA (1994) Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 89(6):2552–2561PubMedCrossRef Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA (1994) Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 89(6):2552–2561PubMedCrossRef
39.
Zurück zum Zitat Dilsizian V (2007) Metabolic adaptation to myocardial ischemia: the role of fatty acid imaging. Springer, Berlin Dilsizian V (2007) Metabolic adaptation to myocardial ischemia: the role of fatty acid imaging. Springer, Berlin
40.
Zurück zum Zitat Abraham A, Nichol G, Williams KA, Guo A, Garrard L, Davies RA, Duchesne L, Haddad H, Chow B, DaSilva J (2010) 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med 51(4):567–574PubMedCrossRef Abraham A, Nichol G, Williams KA, Guo A, Garrard L, Davies RA, Duchesne L, Haddad H, Chow B, DaSilva J (2010) 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med 51(4):567–574PubMedCrossRef
41.
Zurück zum Zitat Dilsizian V (2008) 18F-FDG uptake as a surrogate marker for antecedent ischemia. J Nucl Med 49(12):1909–1911PubMedCrossRef Dilsizian V (2008) 18F-FDG uptake as a surrogate marker for antecedent ischemia. J Nucl Med 49(12):1909–1911PubMedCrossRef
42.
Zurück zum Zitat Schelbert HR (2000) PET contributions to understanding normal and abnormal cardiac perfusion and metabolism. Ann Biomed Eng 28(8):922–929PubMedCrossRef Schelbert HR (2000) PET contributions to understanding normal and abnormal cardiac perfusion and metabolism. Ann Biomed Eng 28(8):922–929PubMedCrossRef
43.
Zurück zum Zitat Taegtmeyer (2016) Assessing cardiac metabolism: a scientific statement from the American Heart Association (vol 118, pg 1659, 2016). Circ Res 118(10):E35–E35CrossRef Taegtmeyer (2016) Assessing cardiac metabolism: a scientific statement from the American Heart Association (vol 118, pg 1659, 2016). Circ Res 118(10):E35–E35CrossRef
44.
Zurück zum Zitat Gong L, Li D, Chen J, Wang X, Xu T, Li W, Ren S, Wang C (2013) Assessment of myocardial viability in patients with acute myocardial infarction by two-dimensional speckle tracking echocardiography combined with low-dose dobutamine stress echocardiography. Int J Cardiovasc Imaging 29(5):1017–1028PubMedCrossRef Gong L, Li D, Chen J, Wang X, Xu T, Li W, Ren S, Wang C (2013) Assessment of myocardial viability in patients with acute myocardial infarction by two-dimensional speckle tracking echocardiography combined with low-dose dobutamine stress echocardiography. Int J Cardiovasc Imaging 29(5):1017–1028PubMedCrossRef
45.
46.
Zurück zum Zitat Hedgire SS, Osborne M, Verdini DJ, Ghoshhajra BB (2017) Updates on stress imaging testing and myocardial viability with advanced imaging modalities. Curr Treat Options Cardiovasc Med 19(4):26PubMedCrossRef Hedgire SS, Osborne M, Verdini DJ, Ghoshhajra BB (2017) Updates on stress imaging testing and myocardial viability with advanced imaging modalities. Curr Treat Options Cardiovasc Med 19(4):26PubMedCrossRef
47.
Zurück zum Zitat Karogiannis N, Senior R (2017) Contrast echocardiography for detection of myocardial perfusion abnormalities. Herz:1–8 Karogiannis N, Senior R (2017) Contrast echocardiography for detection of myocardial perfusion abnormalities. Herz:1–8
48.
Zurück zum Zitat Khawaja OA, Shaikh KA, Al-Mallah MH (2010) Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents. Am J Cardiol 106(5):742–747PubMedCrossRef Khawaja OA, Shaikh KA, Al-Mallah MH (2010) Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents. Am J Cardiol 106(5):742–747PubMedCrossRef
49.
Zurück zum Zitat Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T (2011) Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 364(17):1617–1625PubMedPubMedCentralCrossRef Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T (2011) Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 364(17):1617–1625PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Vanoverschelde J-LJ, D’Hondt A-M, Marwick T, Gerber BL, De Kock M, Dion R, Wijns W, Melin JA (1996) Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 28(2):432–442PubMed Vanoverschelde J-LJ, D’Hondt A-M, Marwick T, Gerber BL, De Kock M, Dion R, Wijns W, Melin JA (1996) Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 28(2):432–442PubMed
51.
Zurück zum Zitat Perrone-Filardi P, Pace L, Prastaro M, Squame F, Betocchi S, Soricelli A, Piscione F, Indolfi C, Crisci T, Salvatore M (1996) Assessment of myocardial viability in patients with chronic coronary artery disease. Circulation 94(11):2712–2719PubMedCrossRef Perrone-Filardi P, Pace L, Prastaro M, Squame F, Betocchi S, Soricelli A, Piscione F, Indolfi C, Crisci T, Salvatore M (1996) Assessment of myocardial viability in patients with chronic coronary artery disease. Circulation 94(11):2712–2719PubMedCrossRef
52.
Zurück zum Zitat Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM (1997) Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 30(6):1451–1460PubMedCrossRef Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM (1997) Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 30(6):1451–1460PubMedCrossRef
53.
Zurück zum Zitat Cho G-Y, Chan J, Leano R, Strudwick M, Marwick TH (2006) Comparison of two-dimensional speckle and tissue velocity based strain and validation with harmonic phase magnetic resonance imaging. Am J Cardiol 97(11):1661–1666PubMedCrossRef Cho G-Y, Chan J, Leano R, Strudwick M, Marwick TH (2006) Comparison of two-dimensional speckle and tissue velocity based strain and validation with harmonic phase magnetic resonance imaging. Am J Cardiol 97(11):1661–1666PubMedCrossRef
54.
55.
Zurück zum Zitat Chan J, Hanekom L, Wong C, Leano R, Cho G-Y, Marwick TH (2006) Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J Am Coll Cardiol 48(10):2026–2033PubMedCrossRef Chan J, Hanekom L, Wong C, Leano R, Cho G-Y, Marwick TH (2006) Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function. J Am Coll Cardiol 48(10):2026–2033PubMedCrossRef
56.
Zurück zum Zitat Cong T, Sun Y, Shang Z, Wang K, Su D, Zhong L, Zhang S, Yang Y (2015) Prognostic value of speckle tracking echocardiography in patients with ST-elevation myocardial infarction treated with late percutaneous intervention. Echocardiography 32(9):1384–1391PubMedCrossRef Cong T, Sun Y, Shang Z, Wang K, Su D, Zhong L, Zhang S, Yang Y (2015) Prognostic value of speckle tracking echocardiography in patients with ST-elevation myocardial infarction treated with late percutaneous intervention. Echocardiography 32(9):1384–1391PubMedCrossRef
57.
Zurück zum Zitat Li DY, Hao J, Xia Y, Zhang H, Xu TD, Wang XP, Zhang YB, Chen J (2012) Clinical usefulness of low-dose dobutamine stress real-time myocardial contrast echocardiography for detection of viable myocardium. J Clin Ultrasound 40(5):272–279PubMedCrossRef Li DY, Hao J, Xia Y, Zhang H, Xu TD, Wang XP, Zhang YB, Chen J (2012) Clinical usefulness of low-dose dobutamine stress real-time myocardial contrast echocardiography for detection of viable myocardium. J Clin Ultrasound 40(5):272–279PubMedCrossRef
58.
Zurück zum Zitat Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, DiFilippo FP, Ficaro EP, Freeman MR, Hendel RC, Jain D (2010) Single photon-emission computed tomography. J Nucl Cardiol 17(5):941–973PubMedCrossRef Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, DiFilippo FP, Ficaro EP, Freeman MR, Hendel RC, Jain D (2010) Single photon-emission computed tomography. J Nucl Cardiol 17(5):941–973PubMedCrossRef
59.
Zurück zum Zitat Ward RP, Al-Mallah MH, Grossman GB, Hansen CL, Hendel RC, Kerwin TC, McCallister BD, Mehta R, Polk DM, Tilkemeier PL (2007) American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomograph myocardial perfusion imaging (SPECT MPI). J Nucl Cardiol 14(6):e26–e38PubMedCrossRef Ward RP, Al-Mallah MH, Grossman GB, Hansen CL, Hendel RC, Kerwin TC, McCallister BD, Mehta R, Polk DM, Tilkemeier PL (2007) American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomograph myocardial perfusion imaging (SPECT MPI). J Nucl Cardiol 14(6):e26–e38PubMedCrossRef
60.
Zurück zum Zitat Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361(9355):374–379PubMedCrossRef Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361(9355):374–379PubMedCrossRef
61.
Zurück zum Zitat AlJaroudi W, Alraies MC, Menon V, Brunken RC, Cerqueira MD, Jaber WA (2012) Predictors and incremental prognostic value of left ventricular mechanical dyssynchrony response during stress-gated positron emission tomography in patients with ischemic cardiomyopathy. J Nucl Cardiol 19(5):958–969PubMedCrossRef AlJaroudi W, Alraies MC, Menon V, Brunken RC, Cerqueira MD, Jaber WA (2012) Predictors and incremental prognostic value of left ventricular mechanical dyssynchrony response during stress-gated positron emission tomography in patients with ischemic cardiomyopathy. J Nucl Cardiol 19(5):958–969PubMedCrossRef
62.
Zurück zum Zitat Köhler D, Arnold R, Loukanov T, Gorenflo M (2013) Right ventricular failure and pathobiology in patients with congenital heart disease—implications for long-term follow-up. Front Pediatr 1:37PubMedPubMedCentralCrossRef Köhler D, Arnold R, Loukanov T, Gorenflo M (2013) Right ventricular failure and pathobiology in patients with congenital heart disease—implications for long-term follow-up. Front Pediatr 1:37PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Al-Mallah MH, Sitek A, Moore SC, Di Carli M, Dorbala S (2010) Assessment of myocardial perfusion and function with PET and PET/CT. J Nucl Cardiol 17(3):498–513PubMedPubMedCentralCrossRef Al-Mallah MH, Sitek A, Moore SC, Di Carli M, Dorbala S (2010) Assessment of myocardial perfusion and function with PET and PET/CT. J Nucl Cardiol 17(3):498–513PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Bulluck H, White SK, Fröhlich GM, Casson SG, O’meara C, Newton A, Nicholas J, Weale P, Wan SM, Sirker A (2016) Quantifying the area at risk in reperfused ST-segment–elevation myocardial infarction patients using hybrid cardiac positron emission tomography–magnetic resonance imaging CLINICAL PERSPECTIVE. Circulation: Cardiovasc Imaging 9(3):e003900 Bulluck H, White SK, Fröhlich GM, Casson SG, O’meara C, Newton A, Nicholas J, Weale P, Wan SM, Sirker A (2016) Quantifying the area at risk in reperfused ST-segment–elevation myocardial infarction patients using hybrid cardiac positron emission tomography–magnetic resonance imaging CLINICAL PERSPECTIVE. Circulation: Cardiovasc Imaging 9(3):e003900
65.
Zurück zum Zitat Schindler TH, Dilsizian V (2012) Cardiac positron emission tomography/computed tomography imaging of the renin-angiotensin system in humans holds promise for image-guided approach to heart failure therapy. J Am Coll Cardiol 60(24):2535–2538. doi:10.1016/j.jacc.2012.09.022 Schindler TH, Dilsizian V (2012) Cardiac positron emission tomography/computed tomography imaging of the renin-angiotensin system in humans holds promise for image-guided approach to heart failure therapy. J Am Coll Cardiol 60(24):2535–2538. doi:10.​1016/​j.​jacc.​2012.​09.​022
66.
Zurück zum Zitat Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, de Boer J, Jager PL (2006) Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET. J Nucl Cardiol 13(2):210–219PubMedCrossRef Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, de Boer J, Jager PL (2006) Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET. J Nucl Cardiol 13(2):210–219PubMedCrossRef
67.
Zurück zum Zitat Gerber B, Ordoubadi F, Wijns W, Vanoverschelde J-L, Knuuti M, Janier M, Melon P, Blanksma P, Bol A, Bax J (2001) Positron emission tomography using18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community concerted action multicenter study on use of18F-fluoro-deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J 22(18):1691–1701PubMedCrossRef Gerber B, Ordoubadi F, Wijns W, Vanoverschelde J-L, Knuuti M, Janier M, Melon P, Blanksma P, Bol A, Bax J (2001) Positron emission tomography using18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community concerted action multicenter study on use of18F-fluoro-deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J 22(18):1691–1701PubMedCrossRef
68.
Zurück zum Zitat Nensa F, Poeppel T, Tezgah E, Heusch P, Nassenstein K, Mahabadi AA, Forsting M, Bockisch A, Erbel R, Heusch G (2015) Integrated FDG PET/MR imaging for the assessment of myocardial salvage in reperfused acute myocardial infarction. Radiology 276(2):400–407PubMedCrossRef Nensa F, Poeppel T, Tezgah E, Heusch P, Nassenstein K, Mahabadi AA, Forsting M, Bockisch A, Erbel R, Heusch G (2015) Integrated FDG PET/MR imaging for the assessment of myocardial salvage in reperfused acute myocardial infarction. Radiology 276(2):400–407PubMedCrossRef
69.
Zurück zum Zitat Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM (1994) Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 23(4):851–859PubMedCrossRef Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM (1994) Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 23(4):851–859PubMedCrossRef
70.
Zurück zum Zitat Bergmann SR, Weinheimer CJ, Markham J, Herrero P (1996) Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 37(10):1723PubMed Bergmann SR, Weinheimer CJ, Markham J, Herrero P (1996) Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 37(10):1723PubMed
71.
Zurück zum Zitat Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE, Babich JW, Udelson JE (2005) Metabolic imaging with β-methyl-p-[123I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 112(14):2169–2174PubMedCrossRef Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE, Babich JW, Udelson JE (2005) Metabolic imaging with β-methyl-p-[123I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 112(14):2169–2174PubMedCrossRef
72.
Zurück zum Zitat Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A (1994) Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 35(11):1758–1765PubMed Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A (1994) Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 35(11):1758–1765PubMed
73.
Zurück zum Zitat Akinboboye O, Bergmann SR (2000) Use of carbon 11-acetate for the measurement of myocardial oxygen consumption. J Nucl Cardiol 7(3):282–285PubMedCrossRef Akinboboye O, Bergmann SR (2000) Use of carbon 11-acetate for the measurement of myocardial oxygen consumption. J Nucl Cardiol 7(3):282–285PubMedCrossRef
74.
Zurück zum Zitat Armbrecht JJ, Buxton DB, Brunken RC, Phelps ME, Schelbert HR (1989) Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C] acetate and dynamic positron tomography. Circulation 80(4):863–872PubMedCrossRef Armbrecht JJ, Buxton DB, Brunken RC, Phelps ME, Schelbert HR (1989) Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C] acetate and dynamic positron tomography. Circulation 80(4):863–872PubMedCrossRef
75.
Zurück zum Zitat Armbrecht JJ, Buxton D, Schelbert H (1990) Validation of [1-11C] acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 81(5):1594–1605PubMedCrossRef Armbrecht JJ, Buxton D, Schelbert H (1990) Validation of [1-11C] acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 81(5):1594–1605PubMedCrossRef
76.
Zurück zum Zitat Rubin PJ, Lee DS, Dávila-Román VG, Geltman EM, Schechtman KB, Bergmann SR, Gropler RJ (1996) Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. Am J Cardiol 78(11):1230–1235PubMedCrossRef Rubin PJ, Lee DS, Dávila-Román VG, Geltman EM, Schechtman KB, Bergmann SR, Gropler RJ (1996) Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. Am J Cardiol 78(11):1230–1235PubMedCrossRef
77.
Zurück zum Zitat Sun KT, Chen K, Sung-Chen H, Buxton DB (1997) Compartment model for measuring myocardial oxygen consumption using (1-(11) C) acetate. J Nucl Med 38(3):459PubMed Sun KT, Chen K, Sung-Chen H, Buxton DB (1997) Compartment model for measuring myocardial oxygen consumption using (1-(11) C) acetate. J Nucl Med 38(3):459PubMed
78.
Zurück zum Zitat Walsh MN, Geltman EM, Brown MA, Henes CG, Weinheimer CJ, Sobel BE, Bergmann SR (1989) Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med 30(11):1798–1808PubMed Walsh MN, Geltman EM, Brown MA, Henes CG, Weinheimer CJ, Sobel BE, Bergmann SR (1989) Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med 30(11):1798–1808PubMed
79.
Zurück zum Zitat Beller GA (2016) Clinical Value of F-18-fluorodeoxyglucose positron emission tomographic imaging of myocardial viability is dependent on adherence to treatment strategy based on imaging results. Circ Cardiovasc Imaging 9(9). doi:10.1161/circimaging.116.005440 Beller GA (2016) Clinical Value of F-18-fluorodeoxyglucose positron emission tomographic imaging of myocardial viability is dependent on adherence to treatment strategy based on imaging results. Circ Cardiovasc Imaging 9(9). doi:10.​1161/​circimaging.​116.​005440
80.
Zurück zum Zitat Mc Ardle B, Shukla T, Nichol G, deKemp RA, Bernick J, Guo A, Lim SP, Davies RA, Haddad H, Duchesne L, Hendry P, Masters R, Ross H, Freeman M, Gulenchyn K, Racine N, Humen D, Benard F, Ruddy TD, Chow BJ, Mielniczuk L, DaSilva JN, Garrard L, Wells GA, Beanlands RSB, Higginson L, Mesana T, Ukkonen H, Yoshinaga K, Renaud J, Klein R, Aung M, Kostuk W, Wisenberg G, White M, Iwanochko RM, Mickleborough L, Abramson B, Latter D, Lamy A, Fallen E, Coates G (2016) Long-term follow-up of outcomes with f-18-fluorodeoxyglucose positron emission tomography imaging–assisted management of patients with severe left ventricular dysfunction secondary to coronary disease CLINICAL PERSPECTIVE. Circ Cardiovasc Imaging 9(9). doi:10.1161/circimaging.115.004331 Mc Ardle B, Shukla T, Nichol G, deKemp RA, Bernick J, Guo A, Lim SP, Davies RA, Haddad H, Duchesne L, Hendry P, Masters R, Ross H, Freeman M, Gulenchyn K, Racine N, Humen D, Benard F, Ruddy TD, Chow BJ, Mielniczuk L, DaSilva JN, Garrard L, Wells GA, Beanlands RSB, Higginson L, Mesana T, Ukkonen H, Yoshinaga K, Renaud J, Klein R, Aung M, Kostuk W, Wisenberg G, White M, Iwanochko RM, Mickleborough L, Abramson B, Latter D, Lamy A, Fallen E, Coates G (2016) Long-term follow-up of outcomes with f-18-fluorodeoxyglucose positron emission tomography imaging–assisted management of patients with severe left ventricular dysfunction secondary to coronary disease CLINICAL PERSPECTIVE. Circ Cardiovasc Imaging 9(9). doi:10.​1161/​circimaging.​115.​004331
81.
Zurück zum Zitat O’Meara E, Mielniczuk LM, Wells GA, Klein R, Coyle D, Mc Ardle B, Paterson I, White JA, Arnold M, Friedrich MG (2013) Alternative imaging modalities in ischemic heart failure (AIMI-HF) IMAGE HF project IA: study protocol for a randomized controlled trial. Trials 14(1):218PubMedPubMedCentralCrossRef O’Meara E, Mielniczuk LM, Wells GA, Klein R, Coyle D, Mc Ardle B, Paterson I, White JA, Arnold M, Friedrich MG (2013) Alternative imaging modalities in ischemic heart failure (AIMI-HF) IMAGE HF project IA: study protocol for a randomized controlled trial. Trials 14(1):218PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Dhingra R, Kirshenbaum L (2015) Succinate dehydrogenase/complex II activity obligatorily links mitochondrial reserve respiratory capacity to cell survival in cardiac myocytes. Nature Publishing Group, New York Dhingra R, Kirshenbaum L (2015) Succinate dehydrogenase/complex II activity obligatorily links mitochondrial reserve respiratory capacity to cell survival in cardiac myocytes. Nature Publishing Group, New York
83.
Zurück zum Zitat Liberman E, Topaly V, Tsofina L, Jasaitis A, Skulachev V (1969) Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 222(5198):1076–1078PubMedCrossRef Liberman E, Topaly V, Tsofina L, Jasaitis A, Skulachev V (1969) Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 222(5198):1076–1078PubMedCrossRef
84.
Zurück zum Zitat Schindler TH, Schelbert HR, Quercioli A, Dilsizian V (2010) Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. J Am Coll Cardiol Img 3(6):623–640CrossRef Schindler TH, Schelbert HR, Quercioli A, Dilsizian V (2010) Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. J Am Coll Cardiol Img 3(6):623–640CrossRef
85.
Zurück zum Zitat Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML, Heymans MW, Tulevski II, van Kuijk C, Hoekstra OS (2013) Hybrid imaging using quantitative H215O PET and CT-based coronary angiography for the detection of coronary artery disease. J Nucl Med 54(1):55–63PubMedCrossRef Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML, Heymans MW, Tulevski II, van Kuijk C, Hoekstra OS (2013) Hybrid imaging using quantitative H215O PET and CT-based coronary angiography for the detection of coronary artery disease. J Nucl Med 54(1):55–63PubMedCrossRef
86.
Zurück zum Zitat Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, Heymans MW, Kajander SA, Pietilä M, James S (2014) Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [15O] H2O PET imaging. J Am Coll Cardiol 64(14):1464–1475PubMedCrossRef Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, Heymans MW, Kajander SA, Pietilä M, James S (2014) Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [15O] H2O PET imaging. J Am Coll Cardiol 64(14):1464–1475PubMedCrossRef
87.
Zurück zum Zitat Hajjiri MM, Leavitt MB, Zheng H, Spooner AE, Fischman AJ, Gewirtz H (2009) Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. J Am Coll Cardiol Img 2(6):751–758CrossRef Hajjiri MM, Leavitt MB, Zheng H, Spooner AE, Fischman AJ, Gewirtz H (2009) Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. J Am Coll Cardiol Img 2(6):751–758CrossRef
88.
Zurück zum Zitat Kajander SA, Joutsiniemi E, Saraste M, Pietilä M, Ukkonen H, Saraste A, Sipilä HT, Teräs M, Mäki M, Airaksinen J (2011) Clinical value of absolute quantification of myocardial perfusion with 15O-water in coronary artery disease clinical perspective. Circulation: Cardiovasc Imaging 4(6):678–684 Kajander SA, Joutsiniemi E, Saraste M, Pietilä M, Ukkonen H, Saraste A, Sipilä HT, Teräs M, Mäki M, Airaksinen J (2011) Clinical value of absolute quantification of myocardial perfusion with 15O-water in coronary artery disease clinical perspective. Circulation: Cardiovasc Imaging 4(6):678–684
89.
Zurück zum Zitat Nesterov SV, Deshayes E, Sciagrà R, Settimo L, Declerck JM, Pan X-B, Yoshinaga K, Katoh C, Slomka PJ, Germano G (2014) Quantification of myocardial blood flow in absolute terms using 82 Rb PET imaging: the RUBY-10 study. J Am Coll Cardiol Img 7(11):1119–1127CrossRef Nesterov SV, Deshayes E, Sciagrà R, Settimo L, Declerck JM, Pan X-B, Yoshinaga K, Katoh C, Slomka PJ, Germano G (2014) Quantification of myocardial blood flow in absolute terms using 82 Rb PET imaging: the RUBY-10 study. J Am Coll Cardiol Img 7(11):1119–1127CrossRef
90.
Zurück zum Zitat Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R, Camici PG, Cerqueira MD, Chow BJ, Di Carli MF (2013) Anatomic versus physiologic assessment of coronary artery disease. J Am Coll Cardiol 62(18):1639–1653PubMedCrossRef Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R, Camici PG, Cerqueira MD, Chow BJ, Di Carli MF (2013) Anatomic versus physiologic assessment of coronary artery disease. J Am Coll Cardiol 62(18):1639–1653PubMedCrossRef
91.
Zurück zum Zitat Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D (2002) Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Circulation 105(2):162–167PubMedCrossRef Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D (2002) Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Circulation 105(2):162–167PubMedCrossRef
92.
Zurück zum Zitat Kühl HP, Beek AM, van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC (2003) Myocardial viability inchronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 41(8):1341–1348PubMedCrossRef Kühl HP, Beek AM, van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC (2003) Myocardial viability inchronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 41(8):1341–1348PubMedCrossRef
93.
Zurück zum Zitat Al-Mallah M, Kwong RY (2008) Clinical application of cardiac CMR. Rev Cardiovasc Med 10(3):134–141 Al-Mallah M, Kwong RY (2008) Clinical application of cardiac CMR. Rev Cardiovasc Med 10(3):134–141
94.
Zurück zum Zitat Al-Mallah MH, Shareef MN (2011) The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy. Heart Fail Rev 16(4):369–380PubMedCrossRef Al-Mallah MH, Shareef MN (2011) The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy. Heart Fail Rev 16(4):369–380PubMedCrossRef
95.
Zurück zum Zitat Baer F, Theissen P, Crnac J, Schmidt M, Deutsch H, Sechtem U, Schicha H, Erdmann E (2000) Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 21(12):981–991PubMedCrossRef Baer F, Theissen P, Crnac J, Schmidt M, Deutsch H, Sechtem U, Schicha H, Erdmann E (2000) Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 21(12):981–991PubMedCrossRef
96.
Zurück zum Zitat Farzaneh-Far A, Kwong RY (2016) Cardiovascular PET/MR: we need evidence, not hype. Springer, Berlin Farzaneh-Far A, Kwong RY (2016) Cardiovascular PET/MR: we need evidence, not hype. Springer, Berlin
97.
Zurück zum Zitat Kim RJ, Farzaneh-Far A (2009) The diagnostic utility of cardiovascular magnetic resonance in patients with chest pain, elevated cardiac enzymes and non-obstructed coronary arteries. Rev Esp Cardiol 62(09):966–971PubMedCrossRef Kim RJ, Farzaneh-Far A (2009) The diagnostic utility of cardiovascular magnetic resonance in patients with chest pain, elevated cardiac enzymes and non-obstructed coronary arteries. Rev Esp Cardiol 62(09):966–971PubMedCrossRef
98.
Zurück zum Zitat Kim HW, Farzaneh-Far A, Kim RJ (2009) Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 55(1):1–16PubMedCrossRef Kim HW, Farzaneh-Far A, Kim RJ (2009) Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 55(1):1–16PubMedCrossRef
99.
Zurück zum Zitat Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM (2001) An improved MR imaging technique for the visualization of myocardial infarction 1. Radiology 218(1):215–223PubMedCrossRef Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM (2001) An improved MR imaging technique for the visualization of myocardial infarction 1. Radiology 218(1):215–223PubMedCrossRef
100.
Zurück zum Zitat Weinmann H-J, Brasch RC, Press W-R, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 142(3):619–624CrossRef Weinmann H-J, Brasch RC, Press W-R, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 142(3):619–624CrossRef
101.
Zurück zum Zitat Rehwald WG, Fieno DS, Chen E-L, Kim RJ, Judd RM (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105(2):224–229PubMedCrossRef Rehwald WG, Fieno DS, Chen E-L, Kim RJ, Judd RM (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105(2):224–229PubMedCrossRef
102.
Zurück zum Zitat Kwong RY, Heydari B, Abbasi S, Steel K, Al-Mallah M, Wu H, Falk RH (2015) Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function. Am J Cardiol 116(4):622–629PubMedPubMedCentralCrossRef Kwong RY, Heydari B, Abbasi S, Steel K, Al-Mallah M, Wu H, Falk RH (2015) Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function. Am J Cardiol 116(4):622–629PubMedPubMedCentralCrossRef
103.
Zurück zum Zitat Fieno DS, Kim RJ, Chen E-L, Lomasney JW, Klocke FJ, Judd RM (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk. J Am Coll Cardiol 36(6):1985–1991PubMedCrossRef Fieno DS, Kim RJ, Chen E-L, Lomasney JW, Klocke FJ, Judd RM (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk. J Am Coll Cardiol 36(6):1985–1991PubMedCrossRef
104.
Zurück zum Zitat Romero J, Xue X, Gonzalez W, Garcia MJ (2012) CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. J Am Coll Cardiol Img 5(5):494–508CrossRef Romero J, Xue X, Gonzalez W, Garcia MJ (2012) CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. J Am Coll Cardiol Img 5(5):494–508CrossRef
105.
Zurück zum Zitat Zemrak F, Petersen SE (2011) Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis 54(3):215–229PubMedCrossRef Zemrak F, Petersen SE (2011) Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis 54(3):215–229PubMedCrossRef
106.
Zurück zum Zitat Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ (2012) Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 308(9):890–896PubMedPubMedCentralCrossRef Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ (2012) Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 308(9):890–896PubMedPubMedCentralCrossRef
107.
Zurück zum Zitat Scott PA, Rosengarten JA, Curzen NP, Morgan JM (2013) Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail 15(9):1019–1027PubMedCrossRef Scott PA, Rosengarten JA, Curzen NP, Morgan JM (2013) Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail 15(9):1019–1027PubMedCrossRef
108.
Zurück zum Zitat Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ (2012) Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 60(5):408–420PubMedPubMedCentralCrossRef Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ (2012) Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 60(5):408–420PubMedPubMedCentralCrossRef
109.
Zurück zum Zitat Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, Erdmann E (1998) Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31(5):1040–1048PubMedCrossRef Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, Erdmann E (1998) Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31(5):1040–1048PubMedCrossRef
110.
Zurück zum Zitat Uecker M, Zhang S, Voit D, Karaus A, Merboldt KD, Frahm J (2010) Real-time MRI at a resolution of 20 ms. NMR Biomed 23(8):986–994PubMedCrossRef Uecker M, Zhang S, Voit D, Karaus A, Merboldt KD, Frahm J (2010) Real-time MRI at a resolution of 20 ms. NMR Biomed 23(8):986–994PubMedCrossRef
111.
Zurück zum Zitat Zhang S, Block KT, Frahm J (2010) Magnetic resonance imaging in real time: advances using radial FLASH. J Magn Reson Imaging 31(1):101–109PubMedCrossRef Zhang S, Block KT, Frahm J (2010) Magnetic resonance imaging in real time: advances using radial FLASH. J Magn Reson Imaging 31(1):101–109PubMedCrossRef
112.
Zurück zum Zitat Zhang S, Uecker M, Voit D, Merboldt K-D, Frahm J (2010) Real-time cardiovascular magnetic resonance at high temporal resolution: radial FLASH with nonlinear inverse reconstruction. J Cardiovasc Magn Reson 12(1):39PubMedPubMedCentralCrossRef Zhang S, Uecker M, Voit D, Merboldt K-D, Frahm J (2010) Real-time cardiovascular magnetic resonance at high temporal resolution: radial FLASH with nonlinear inverse reconstruction. J Cardiovasc Magn Reson 12(1):39PubMedPubMedCentralCrossRef
113.
Zurück zum Zitat Al-Mallah MH, Aljizeeri A, Villines TC, Srichai MB, Alsaileek A (2015) Cardiac computed tomography in current cardiology guidelines. J Cardiovasc Computed Tomogr 9(6):514–523CrossRef Al-Mallah MH, Aljizeeri A, Villines TC, Srichai MB, Alsaileek A (2015) Cardiac computed tomography in current cardiology guidelines. J Cardiovasc Computed Tomogr 9(6):514–523CrossRef
114.
Zurück zum Zitat Al-Mallah MH, Aljizeeri A, Alharthi M, Alsaileek A (2014) Routine low-radiation-dose coronary computed tomography angiography. Eur Heart J Suppl 16(suppl B):B12–B16CrossRef Al-Mallah MH, Aljizeeri A, Alharthi M, Alsaileek A (2014) Routine low-radiation-dose coronary computed tomography angiography. Eur Heart J Suppl 16(suppl B):B12–B16CrossRef
115.
Zurück zum Zitat Mahnken AH, Koos R, Katoh M, Wildberger JE, Spuentrup E, Buecker A, Günther RW, Kühl HP (2005) Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 45(12):2042–2047PubMedCrossRef Mahnken AH, Koos R, Katoh M, Wildberger JE, Spuentrup E, Buecker A, Günther RW, Kühl HP (2005) Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 45(12):2042–2047PubMedCrossRef
116.
Zurück zum Zitat Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39(7):1151–1158PubMedCrossRef Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39(7):1151–1158PubMedCrossRef
117.
Zurück zum Zitat Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J (1995) Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92(12):3436–3444PubMedCrossRef Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J (1995) Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92(12):3436–3444PubMedCrossRef
118.
Zurück zum Zitat Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, Valkema R, Van Lingen A, Fioretti PM, Visser CA (2001) Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 42(1):79–86PubMed Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, Valkema R, Van Lingen A, Fioretti PM, Visser CA (2001) Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med 42(1):79–86PubMed
119.
Zurück zum Zitat Marwick TH, Zuchowski C, Lauer MS, Secknus M-A, Williams MJ, Lytle BW (1999) Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 33(3):750–758PubMedCrossRef Marwick TH, Zuchowski C, Lauer MS, Secknus M-A, Williams MJ, Lytle BW (1999) Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 33(3):750–758PubMedCrossRef
120.
Zurück zum Zitat Dalle Mule J, Bax JJ, Zingone B, Martinelli F, Burelli C, Stefania A, DiSipio L, Soravia G (2002) The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis. Eur J Cardiothorac Surg 22(3):426–430CrossRef Dalle Mule J, Bax JJ, Zingone B, Martinelli F, Burelli C, Stefania A, DiSipio L, Soravia G (2002) The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis. Eur J Cardiothorac Surg 22(3):426–430CrossRef
121.
Zurück zum Zitat Rohatgi R, Epstein S, Henriquez J, Ala’eldin AA, Hickey KT, Pinsky D, Akinboboye O, Bergmann SR (2001) Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. Am J Cardiol 87(9):1096–1099PubMedCrossRef Rohatgi R, Epstein S, Henriquez J, Ala’eldin AA, Hickey KT, Pinsky D, Akinboboye O, Bergmann SR (2001) Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. Am J Cardiol 87(9):1096–1099PubMedCrossRef
122.
Zurück zum Zitat Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, DiSesa VJ, Hiratzka LF, Hutter AM (2011) 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. Circulation. 0b013e31823c31074e Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, DiSesa VJ, Hiratzka LF, Hutter AM (2011) 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. Circulation. 0b013e31823c31074e
123.
Zurück zum Zitat Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, Guo A, Ruddy TD (2007) F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 50(20):2002–2012PubMedCrossRef Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, Guo A, Ruddy TD (2007) F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 50(20):2002–2012PubMedCrossRef
124.
Zurück zum Zitat Cleland JG, Calvert M, Freemantle N, Arrow Y, Ball SG, Bonser RS, Chattopadhyay S, Norell MS, Pennell DJ, Senior R (2011) The HEART failure revascularisation trial (HEART). Eur J Heart Fail 13(2):227–233PubMedCrossRef Cleland JG, Calvert M, Freemantle N, Arrow Y, Ball SG, Bonser RS, Chattopadhyay S, Norell MS, Pennell DJ, Senior R (2011) The HEART failure revascularisation trial (HEART). Eur J Heart Fail 13(2):227–233PubMedCrossRef
125.
Zurück zum Zitat Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364(17):1607–1616PubMedPubMedCentralCrossRef Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364(17):1607–1616PubMedPubMedCentralCrossRef
126.
Zurück zum Zitat Alanbaei M, Zubaid M, Al-Mallah MH, Rashed WA, Shehab A, Al-Lawati J, ChB M, Amin H, Suwaidi JA, Al-Hamdan R (2012) Impact of diabetes and smoking epidemic in the Middle East on the presentation with acute coronary syndrome in very young patients. Angiology 63(1):48–54PubMedCrossRef Alanbaei M, Zubaid M, Al-Mallah MH, Rashed WA, Shehab A, Al-Lawati J, ChB M, Amin H, Suwaidi JA, Al-Hamdan R (2012) Impact of diabetes and smoking epidemic in the Middle East on the presentation with acute coronary syndrome in very young patients. Angiology 63(1):48–54PubMedCrossRef
Metadaten
Titel
The role of myocardial viability in contemporary cardiac practice
verfasst von
Abdelrahman Jamiel
Mohamad Ebid
Amjad M. Ahmed
Dalia Ahmed
Mouaz H. Al-Mallah
Publikationsdatum
03.06.2017
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 4/2017
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-017-9626-3

Weitere Artikel der Ausgabe 4/2017

Heart Failure Reviews 4/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.